drug
fexofenadine hydrochloride
Marketedupdated 3mo agoby Chattem Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- drugFEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE13 co-mentions · 4 sources
- tagApproval12 co-mentions · 3 sources
- tagSmall Molecule6 co-mentions · 3 sources
- company$PRGOPERRIGO Co plc2 co-mentions · 1 sources
- drugpseudoephedrine hydrochloride ER2 co-mentions · 1 sources
- drugPSEUDOEPHEDRINE HYDROCHLORIDE2 co-mentions · 1 sources
- companyNorthwestern University1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 11 approved and 2 investigational indications.
all catalysts(1)
Trials studying fexofenadine hydrochloride
- N/AInvestigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis
- N/AInvestigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis
- phase1Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg
- phase1Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg
- N/AAll Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 2, 2030
~4.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Aug 2, 2030formulationUS 89330974.0y
- Aug 2, 2030formulationUS 89330974.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that